http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6525097-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-175 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-305 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate | 2000-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea1344ed6dfb7cb30bb7e6bec3c402ca |
| publicationDate | 2003-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6525097-B1 |
| titleOfInvention | Method of treating a cancerous condition by enhancing the effectiveness of the human immune system |
| abstract | There is disclosed a method of treating a cancerous condition in a person in need of such treatment, which comprises enhancing the effectiveness of the person's immune system by the administration to such person of at least one aliphatic sulfur compound, preferably a sulfur-containing amino-acid derivative having the formula (I)in which A is hydrogen or a carboxymethylene -CH2CO2H group, B is hydrogen or an alkyl group having 1 to 3 carbon atoms, and X is hydrogen, or an acyl group -CO-R in which R is an alkyl group having 1 to 3 carbon atoms, or a pharmaceutically acceptable salt of such compound. |
| priorityDate | 2000-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.